TASIGNA caps 200 mg 112 pce

7680580070025 CH-58007 L01EA03 07.16.1.

Active substances:

TASIGNA caps 200 mg 112 pce
Fiches Amavita / Sun Store / Coop Vitality

Details

Product number
5800701
CPT
-
Packaging group
112
Unit
Kapsel(n)
Composition
nilotinibum 200 mg ut nilotinibi hydrochloridum monohydricum, lactosum monohydricum 156.11 mg, crospovidonum, poloxamerum 188, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: gelatina, E 171, E 172 (flavum), Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, kalii hydroxidum, E 172 (rubrum), pro capsula.

Articles (1)

Tasigna 200 mg, Kapseln
Kapseln
112
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
09/08/2022
Patient information leaflet
Français
09/08/2022
Patient information leaflet
Italien
09/08/2022
Professional SmPC
Allemand
09/08/2022
Professional SmPC
Français
09/08/2022
Professional SmPC
Italien
09/08/2022

Detailed composition

Substance Quantity Type Category
nilotinibum
200.0 MG Substance Wirkstoff (Principe actif)
nilotinibi hydrochloridum monohydricum
- Substance WIZUS
lactosum monohydricum
156.11 MG Substance HBESI
crospovidonum
- Substance HNIDK
poloxamerum 188
- Substance HNIDK
silica colloidalis anhydrica
- Substance HNIDK
magnesii stearas
- Substance HNIDK
gelatina
- Substance HNIDK
E 171
- Substance FNIDK
E 172 (flavum)
- Substance FTODK
lacca
- Substance HNIDK
propylenglycolum
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
ammoniae solutio concentrata
- Substance HNIDK
kalii hydroxidum
- Substance HNIDK
E 172 (rubrum)
- Substance FTODK

Reimbursement information

Public price
CHF 3001.85
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/08/2007

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
58007
Drug name
Tasigna, Kapseln
Galenic form
KAHA
ATC Code
L01EA03
Authorization status
Z
Dispensation category
A
First authorization
24/07/2007
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Behandlung der chronischen myeloischen Leukämie

Packaging details

Description (FR)
TASIGNA caps 200 mg 112 pce
Description (DE)
TASIGNA Kaps 200 mg 112 Stk
Market launch
24/07/2007
Narcotic (BTM)
No

Available generics

Nilotinib Accord, Hartkapseln
CHF 1036.95
View
Nilotinib Accord, Hartkapseln
CHF 484.75
View
Nilotinib Accord, Hartkapseln
CHF 1552.60
View
Nilotinib Zentiva, Hartkapseln
CHF 1018.20
View
Nilotinib Zentiva, Hartkapseln
CHF 483.60
View
Nilotinib Zentiva, Hartkapseln
CHF 1552.20
View

Other packaging sizes

TASIGNA caps 200 mg 28 pce
28 KAP
View
TASIGNA caps 150 mg 112 pce
112 KAP
View
TASIGNA caps 50 mg 120 pce
120 KAP
View
Buy us a coffee Explore the data